Tag: state policies

States Expand Access to Affordable Private Coverage for Immigrant Populations

In the United States, immigrants are disproportionately likely to be uninsured. This disparity stems from systemic inequalities such as legal barriers to affordable coverage for noncitizens—especially undocumented immigrants. While state efforts to provide Medicaid-equivalent benefits to some populations of undocumented residents have helped expand access to coverage, many low- and moderate-income undocumented residents remain without affordable health insurance options. In a recent post for the Commonwealth Fund’s To the Point blog, CHIR’s Justin Giovannelli and Rachel Schwab explore recent state actions to fill this gap.

One Victim of the COVID-19 Pandemic? State Health Policy

State legislative sessions are typically a flurry of health policy activity. In recent years, state lawmakers have taken action to stabilize their insurance markets and increase access to coverage. But like so many other constants we have come to rely on, state legislative sessions took a hit this year from the novel coronavirus pandemic, putting current and future state policy initiatives in jeopardy.

New Resource for Consumer Advocates on Out-of-Network Payment Disputes in Balance Billing Legislation

State lawmakers across the country are are gearing up for a new legislative session. Many will be considering state-level protections for consumers to prevent surprise out-of-network medical bills. Just as with the federal legislation, however, one of the key sticking points for state policymakers will be how to approach out-of-network provider reimbursement. To aid stakeholders in these efforts, Community Catalyst teamed up with CHIR experts to create a guide for its health insurance reform toolkit: The Advocate’s Guide to Addressing Out-Of-Network Payment in Surprise Balance Billing Legislation.

States Take the Lead with Policies to Protect Residents with Chronic Conditions from High Out-of-Pocket Drug Costs

Lowering the cost of prescription medication has broad support over the political spectrum and there were many campaign promises to reduce prices. But to date, there’s been little federal action. States, however, are taking the lead with policies designed to protect consumers with chronic conditions from high out-of-pocket costs associated with expensive specialty drugs. A new CHIR brief details the findings from a 50-state survey of such policies and observations from supplementary interviews with state regulators, insurance company representatives and consumer advocates.

The opinions expressed here are solely those of the individual blog post authors and do not represent the views of Georgetown University, the Center on Health Insurance Reforms, any organization that the author is affiliated with, or the opinions of any other author who publishes on this blog.